InvestorsHub Logo
Followers 25
Posts 2423
Boards Moderated 0
Alias Born 07/25/2013

Re: None

Wednesday, 04/26/2017 5:45:20 AM

Wednesday, April 26, 2017 5:45:20 AM

Post# of 345792
TARGETING THE TUMOR MICROENVIRONMENT: ACTIVATING THE IMMUNE SYSTEM FOR BETTER RESPONSE TO IMMUNOTHERAPY

2:30 Intratumoral Immunotherapy: Overcoming Immune Resistance and Activating the Adaptive and Innate Immune Responses

Adi Diab, M.D., Assistant Professor, Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center


http://www.immuno-oncologysummit.com/Preclinical-Immuno-Oncology/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News